BCI hydrochloride - NSC 150117 hydrochloride

Based on 14 reference(s) in Google Scholar 8 10 14

Axon 2852

CAS [95130-23-7]

MF C22H23NO.HCl
MW 353.89

  • Purity: 100%
  • Soluble in DMSO
Recently added

BCI hydrochloride

Description

Allosteric inhibitor of dual-specificity phosphatases (DUSP). BCI treatment of DUSP6-Myc–transfected cells blocks DUSP6 or DUSP1 activity, but not DUSP5 (IC50 values 12.3 μM and 11.5 μM for DUSP6 and DUSP1 inhibition, resp.). BCI mediated DUSP6 inhibition can induce expansion of myocardial progenitors that ultimately increases heart size in zebrafish embryos. BCI also inhibits lung cancer and uveal melanoma cells viability (IC50 values ranging from 0.1 to 90 μM). The dual-specificity phosphatase 6 (DUSP6) functions a feedback regulator of fibroblast growth factor (FGF) signaling to limit the activity of extracellular signal–regulated kinases (ERKs) 1 and 2.

The free base BCI is also available as Axon 2178.

KEYWORDS: BCI hydrochloride | supplier | DUSP inhibitor | NSC 150117 hydrochloride | NSC150117 hydrochloride | NSC-150117 hydrochloride | CAS [95130-23-7] | [1245792-51-1] | Non Selective (Serine-Threonine and Tyrosine Specific Phosphodiesters) | DUSP | Inhibitor | Enzymes

Order
Size Unit Price Stock
10 mg €75.00 In Stock
50 mg €285.00 In Stock
Need more? Bulk Inquiry

The purity of Axon Ligands™ is confirmed by HPLC-MS, 1H-NMR and/or microanalysis. Analytical data are available upon request.

Caution: Axon Ligands™ are not fully tested. They are for research purposes only! Not for human consumption!

Please wait...